EUVIMEDEUVIMED entdecken
Crossref

Adoptive transfer of interleukin-4 programmed macrophages reduces lung inflammation during betacoronavirus infection

Franciel Batista Felix, Vinicius Amorim Beltrami, Ana Paula Soares da Cruz Maravilha, Débora Gonzaga Martins, Letícia Cassiano Resende, Edvaldo Souza Lara, Fernanda Silva Carneiro, Débora de Oliveira Fernandes, Fernanda de Lima Tana, Pedro Henrique de Sousa Palmeira, Juliana Priscila Vago, Celso Martins Queiroz-Junior und 4 weitere

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.117186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Franciel Batista Felix und 15 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil; Instituto de Ci…. Hauptthemen laut MEDLINE: Interleukin-4, Murine hepatitis virus, Macrophages, Coronavirus Infections. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Murine interleukin-4-educated macrophages (M(IL4)) exert well-established anti-inflammatory effects. Here, we sought to determine whether bone marrow-derived M(IL4) could attenuate lung inflammation and serve as a cell-based therapeutic strategy for viral infectious diseases. Mice were intranasally infected with murine hepatitis virus (MHV)-A59. M(IL4)s generated in vitro were intravenously transferred into mice infected with MHV-A59 in two doses administered on days 3 and 4 post-infection. The distribution of transferred cells was examined by flow cytometry. Lung histopathology, chemokines (CXCL-1, CCL3, and CCL2), cytokines (IL-1β, TNF, and IFN-γ), viral titers, blood cell counts, and macrophage subsets were evaluated. Transferred M(IL4)s localized to the lung and bronchoalveolar lavage fluid (BALF), and the cells retained their anti-inflammatory capacity. Systemic delivery of M(IL4) attenuated MHV-A59-induced inflammatory responses, as evidenced by reduced pro-inflammatory cytokine levels, decreased lung tissue damage, and enhanced viral clearance. Moreover, M(IL4) therapy reduced the abundance of inflammatory macrophages and expression of MHC class II and CD80 markers while favoring the expansion of anti-inflammatory subsets in both BALF and lung tissue of MHV-A59-infected mice. These data provide important insights into the therapeutic potential of macrophage-based cell therapy in virus-induced lung inflammation and pave the way for further investigation of macrophages as therapy for individuals with severe cases of respiratory viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-4Murine hepatitis virusMacrophagesCoronavirus InfectionsAdoptive TransferLungPneumoniaAnimalsMiceCytokinesMice, Inbred C57BLFemaleBronchoalveolar Lavage Fluid

Stichwörter der Autor:innen

ImmunotherapyLung inflammationMHV-A59Macrophage-based therapy

Substanzen

Interleukin-4Cytokines

Autor:innen und Institutionen

  • Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil; Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas, Maceió…
  • Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
  • Signaling in Inflammation Lab., Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
  • Department of Immunobiology, Yale University, New Haven, CT, USA.
  • Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
  • Department of Physiology and Pharmacology, Calvin, Phoebe & Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Zitieren

APA

Felix, F. B., Beltrami, V. A., da Cruz Maravilha, A. P. S., Martins, D. G., Resende, L. C., Lara, E. S., Carneiro, F. S., de Oliveira Fernandes, D., de Lima Tana, F., de Sousa Palmeira, P. H., Vago, J. P., Queiroz-Junior, C. M., de Sousa, L. P., McKay, D. M., Teixeira, M. M., & Pinho, V. (2026). Adoptive transfer of interleukin-4 programmed macrophages reduces lung inflammation during betacoronavirus infection. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117186

Vancouver

Felix FB, Beltrami VA, da Cruz Maravilha APS, Martins DG, Resende LC, Lara ES, et al. Adoptive transfer of interleukin-4 programmed macrophages reduces lung inflammation during betacoronavirus infection. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117186

BibTeX
@article{Felix2026,
  author = {Felix, Franciel Batista and Beltrami, Vinicius Amorim and da Cruz Maravilha, Ana Paula Soares and Martins, Débora Gonzaga and Resende, Letícia Cassiano and Lara, Edvaldo Souza and Carneiro, Fernanda Silva and de Oliveira Fernandes, Débora and de Lima Tana, Fernanda and de Sousa Palmeira, Pedro Henrique and Vago, Juliana Priscila and Queiroz-Junior, Celso Martins and de Sousa, Lirlandia Pires and McKay, Derek M and Teixeira, Mauro Martins and Pinho, Vanessa},
  title = {Adoptive transfer of interleukin-4 programmed macrophages reduces lung inflammation during betacoronavirus infection},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.117186}
}
Kostenlos starten →